[1] Jiang L, Shen J, Zhang N, He Y, Wan Z. Association of RGS20 expression with the progression and prognosis of renal cell carcinoma. Oncol Lett. 2021 Sep;22(3):643. doi: 10.3892/ol.2021.12904. Epub 2021 Jul 7. PMID: 34386065; PMCID: PMC8299006.
[2] Lai MC, Zhu QQ, Xu J, Zhang WJ. Experimental and clinical evidence suggests that GRPEL2 plays an oncogenic role in HCC development. Am J Cancer Res. 2021 Sep 15;11(9):4175-4198. PMID: 34659882; PMCID: PMC8493396.
[3] Chen S, Chen X, Li Z, Mao J, Jiang W, Zhu Z, Li Y, Jiang Z, Zhao W, Tan G, Wang Z. Identification of ubiquitin-specific protease 32 as an oncogene in glioblastoma and the underlying mechanisms. Sci Rep. 2022 Apr 19;12(1):6445. doi: 10.1038/s41598-022-09497-y. PMID: 35440702; PMCID: PMC9018837.
[4] Hong Z, Pan J, Chen M, Deng X, Chen Z, Wang C, Qiu C. Long Intergenic Noncoding RNA 00641 Promotes Growth and Invasion of Colorectal Cancer through Regulating miR-450b-5p/GOLPH3 Axis. J Oncol. 2022 Jun 15;2022:8259135. doi: 10.1155/2022/8259135. PMID: 35756081; PMCID: PMC9217543.
[5] Ma T, Tian X, Zhang B, Li M, Wang Y, Yang C, Wu J, Wei X, Qu Q, Yu Y, Long S, Feng JW, Li C, Zhang C, Xie C, Wu Y, Xu Z, Chen J, Yu Y, Huang X, He Y, Yao L, Zhang L, Zhu M, Wang W, Wang ZC, Zhang M, Bao Y, Jia W, Lin SY, Ye Z, Piao HL, Deng X, Zhang CS, Lin SC. Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature. 2022 Mar;603(7899):159-165. doi: 10.1038/s41586-022-04431-8. Epub 2022 Feb 23. PMID: 35197629; PMCID: PMC8891018.
[6] Wang, L., Ma, X., Chen, Y., Zhang, J., Zhang, J. et al. (2022). MiR-145-5p Suppresses Hepatocellular Carcinoma Progression by Targeting ABHD17C. Oncologie, 24(4), 897–912.
[7] Liang H, Hu C, Lin X, He Z, Lin Z, Dai J. MiR-548d-3p Promotes Gastric Cancer by Targeting RSK4. Cancer Manag Res. 2020 Dec 24;12:13325-13337. doi: 10.2147/CMAR.S278691. PMID: 33380838; PMCID: PMC7769082.